Loading...
Loading...
Application UK00917034646 · Registered

| Application Number | UK00917034646 |
| Status | Registered |
| Owner | Medicover Holding (Cyprus) Limited |
| Filed | 2017-07-27 |
| Registered | 2017-11-14 |
| Renewal Due | 2027-07-27 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Yes. SYNEVO is currently a registered UK trademark, with renewal due on 2027-07-27. It is protected under UK intellectual property law and can be enforced against infringing uses.
Colour Claimed : Blue; White.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Research in the field of medicine and pharmacology; Medical laboratory services; Analysis of human tissues for medical research; Laboratory services relating to the production of monoclonal antibodies; Medical research; Scientific research for medical purposes in the area of cancerous diseases; Scientific investigations for medical purposes; Research services; Provision of research services; Scientific research; Biomedical research services; Biological research; Bacteriological research; Research relating to biotechnology; Genetic research; Biological research, clinical research and medical research; Chemical analysis and research, including analysis relating to medicines, pharmaceuticals and biochemistry; Research laboratories; Research on the subject of pharmaceuticals; Bacteriological research and testing; Blood analysis services for scientific research purposes; Research in the field of gene therapy; Toxicity testing for research purposes; DNA screening for scientific research purposes; Cell separation research services; Scientific research relating to bacteriology; Research and development services in the field of antibodies; Research and development services in the field of immunology; Research and development services in the field of cytology; Research and development services in the field of bacteriology; Research and development services in the field of immunohistology; Preparation of immunohistological samples for analysis in research laboratories; Preparation of biological samples for analysis in research laboratories; Scientific research in the field of genetics and genetic engineering.
Human healthcare services; Consulting services relating to health care; Advice relating to dentistry; Nutritional advice; Psychological counseling; Medical information; Medical clinic services; Medical consultations; Dental consultations; Nutrition consultancy; Medical services; Medical examination of individuals; Medical care; Medical nursing; Health centers; Services for the provision of medical facilities; Conducting of medical examinations; Performing diagnosis of diseases; Preparation of reports relating to medical matters; Psychiatric services; Psychotherapy services; Holistic psychotherapy; Reflexology; Physical rehabilitation; Providing online medical record services other than dentistry; Hospitals; Physician services; Dentistry; Telemedicine services; Pharmaceutical services; Trans-telephone heart monitoring services; Sports medicine services; Medical health assessment services; Health care services offered through a network of health care providers on a contract basis; Services for the testing of blood; Blood bank services; Cord blood bank services; Collection and preservation of human blood; DNA screening for medical purposes; Pathology services; Medical screening; Cholesterol testing; Genetic testing for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; Services for the testing of sera; Services for the testing of urine; Medical testing services relating to the diagnosis and treatment of disease; Medical analysis services for cancer diagnosis and prognosis; Medical analysis services relating to the treatment of persons; Medical analysis services relating to the treatment of patients; Medical analysis for the diagnosis and treatment of persons; Medical diagnostic services; Medical services relating to the removal, treatment and processing of bone marrow; Medical services relating to the removal, treatment and processing of umbilical cord blood; Medical services relating to the removal, treatment and processing of stem cells; Medical services relating to the removal, treatment and processing of human blood; Medical services relating to the removal, treatment and processing of human cells; Medical and health services relating to DNA, genetics and genetic testing; Medical services for the treatment of conditions of the human body; Medical services for the diagnosis of conditions of the human body; Medical laboratory services for the analysis of samples taken from patients; Medical laboratory services for the analysis of blood samples taken from patients; Analysis of human tissues for medical treatment.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
'SYNEVO' is a registered trademark on the UK IPO register, owned by Medicover Holding (Cyprus) Limited. The application (UK00917034646) was filed on 27 July 2017 and registered on 14 November 2017. The registration is set to expire on 27 July 2027.
This mark is recorded under multiple classes: Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services), specifically covering: Colour Claimed : Blue; White.
The trademark is represented by Barker Brettell LLP.
UK trademark UK00917034646 for the mark 'SYNEVO' in Class 42, 44 is recorded on the UK IPO register as owned by Medicover Holding (Cyprus) Limited. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00917034646 for the mark 'SYNEVO' as registered.
UK trademark UK00917034646 for the mark 'SYNEVO' is recorded in Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 42: Research in the field of medicine and pharmacology; Medical laboratory services; Analysis of human tissues for medical research; Laboratory services relating to the production of monoclonal antibodies; Medical research; Scientific research for medical purposes in the area of cancerous diseases; Scientific…
UK trademark UK00917034646 for the mark 'SYNEVO' was filed at the UK IPO on 27 July 2017 and registered on 14 November 2017.
UK trademark UK00917034646 for the mark 'SYNEVO' is currently recorded as valid until 27 July 2027, at which point it will need to be renewed with the UK IPO to remain in force.
Barker Brettell LLP is listed as the attorney / representative of record for UK trademark UK00917034646 for the mark 'SYNEVO' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.